Clinical trials
Completed Phase 1/2 Blast Crisis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 4 |
| 2003 | 5 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| M.D. Anderson Cancer Center | 6 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Cancer Institute (NCI) | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Asan Medical Center | 1 |
| Cancer Treatment Centers of America | 1 |
| Drexel University College of Medicine | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blast Crisis | 29 |
| Leukemia | 20 |
| Leukemia, Myeloid, Accelerated Phase | 20 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 20 |
| Leukemia, Myeloid, Acute | 19 |
| Myelodysplastic Syndromes | 16 |
| Leukemia, Myeloid, Chronic-Phase | 12 |
| Hodgkin Disease | 10 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 10 |
| Lymphoma, Non-Hodgkin | 10 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.